Silo Pharma, a Nasdaq-listed company, has completed its inaugural Bitcoin purchase, though the specific amount and quantity remain undisclosed. This move aligns with the company's strategy to diversify its digital asset holdings, which already include Ethereum (ETH), RSC, and Solana (SOL). The acquisition marks Silo Pharma's continued expansion into the cryptocurrency market as part of its broader treasury management approach.